Structure and Function of Biomolecules Short Notes
One-page CSIR NET revision for Unit 1: weak forces, buffers, thermodynamics, DNA forms, protein structure, enzyme kinetics, bioenergetics and metabolism.
- 8 min
On this page · 10 sections
The whole of Unit 1 on one page. For explanations and worked problems, go back to the chapter: Chemical Bonds and Biophysical Chemistry, Carbohydrates, Lipids, Nucleic Acids and Vitamins, Protein Structure and Stability, Enzymes and Bioenergetics and Metabolism.
Forces and Biophysical Chemistry
| Fact | Detail |
|---|---|
| Thermal energy RT | 2.48 kJ/mol at 25 °C; 2.58 kJ/mol at 37 °C |
| Weak interactions | Ionic (long range, screened by salt), H-bond (directional), van der Waals (r⁻⁶ attraction, r⁻¹² repulsion), hydrophobic (entropy of water) |
| Dielectric constant | Water about 78.5; hexane about 2 → ion pairs much stronger in non-polar interiors |
| Main driving force of folding and bilayers | Hydrophobic effect |
| Kw | 1.0 × 10⁻¹⁴ M² at 25 °C |
| Henderson–Hasselbalch | pH = pKa + log([A⁻]/[HA]) |
| Buffer | Capacity maximal at pH = pKa; range pKa ± 1; dilution does not change pH |
| pKa values | Acetate 4.76; phosphate pKa₂ 6.86; bicarbonate (apparent) 6.1; His side chain about 6; Tris about 8.1 |
| Blood | 24 mM HCO₃⁻, pCO₂ 40 mmHg → 20:1 → pH 7.40 |
| pI | Neutral R: average of 2 pKa; Gly 5.97, Asp 2.77, Lys 9.74, His 7.59 |
| Ion exchange | Below pI → cation exchanger (CM); above pI → anion exchanger (DEAE) |
| First-order half-life | 0.693/k, independent of [A]₀ |
| Arrhenius / Eyring | k = A e^(−Ea/RT); k = (k_BT/h) e^(−ΔG‡/RT); k_BT/h about 6.2 × 10¹² s⁻¹ |
| Gibbs | ΔG = ΔH − TΔS; ΔG = ΔG°’ + RT ln Q |
| ΔG°' | −RT ln K’eq; 5.71 kJ/mol per tenfold K at 25 °C |
| Redox | ΔG°’ = −nFΔE°’; F = 96.485 kJ V⁻¹ mol⁻¹ |
| Catalysts | Lower ΔG‡ only; K’eq unchanged |
| Colligative | Vapour pressure ↓, boiling point ↑, freezing point ↓, π = iMRT |
| Water constants | Kf 1.86, Kb 0.512 K kg mol⁻¹ |
Carbohydrates and Lipids
| Fact | Detail |
|---|---|
| Stereoisomers | 2ⁿ; aldohexose 16 |
| D/L | Configuration at the chiral carbon farthest from the carbonyl (C5 of hexoses) |
| Epimers of glucose | Mannose (C2), galactose (C4) |
| Anomers | α/β at C1 (aldoses) or C2 (ketoses); mutarotation; glucose about 1/3 α, 2/3 β |
| Non-reducing | Sucrose (Glc α1↔2β Fru), trehalose (Glc α1↔1α Glc) |
| Lactose / maltose | Gal β1→4 Glc / Glc α1→4 Glc (both reducing) |
| Starch vs cellulose | α1→4 helix vs β1→4 straight fibres |
| Branching | Glycogen every 8–12; amylopectin every 24–30 residues (α1→6) |
| Chitin / peptidoglycan | GlcNAc β1→4 / GlcNAc–MurNAc β1→4 + peptides |
| N-glycosylation | Asn-X-Ser/Thr (X ≠ Pro); O-linked on Ser/Thr |
| Fatty acid notation | C:D(Δⁿ) from carboxyl; ω from methyl end |
| Essential fatty acids | Linoleic 18:2 (ω-6), α-linolenic 18:3 (ω-3) |
| Melting point | Rises with length; falls with cis double bonds |
| Sphingolipids | Ceramide; sphingomyelin; cerebroside; ganglioside (sialic acid) |
| Phospholipase C | PIP₂ → IP₃ + DAG |
| Cholesterol | C27, 3-OH; buffers membrane fluidity |
Nucleic Acids
| Fact | Detail |
|---|---|
| Glycosidic bond | β-N9 (purines), β-N1 (pyrimidines) |
| Chargaff | A = T, G = C in dsDNA |
| Base pairs | G·C three H-bonds; A·T two |
| B-DNA | Right-handed, 10.5 bp/turn, 3.4 Å rise, about 20 Å diameter, C2’-endo, anti; wide major groove |
| A-DNA | Right-handed, about 11 bp, 2.6 Å, about 26 Å, C3’-endo; dehydrated DNA, RNA duplexes and hybrids |
| Z-DNA | Left-handed, about 12 bp, 3.7 Å, about 18 Å, syn purines, dinucleotide repeat; (CG)ₙ, high salt, negative supercoiling |
| Other structures | Cruciform (palindromes), triplex H-DNA (Hoogsteen), G-quadruplex (K⁺) |
| Topology | Lk = Tw + Wr; Lk₀ = bp/10.5; σ = ΔLk/Lk₀ (about −0.06 in cells) |
| Topoisomerases | I: ΔLk ±1, no ATP; II/gyrase: ΔLk ±2, ATP |
| RNA | A-form helices; hairpins, bulges, pseudoknots; G·U wobble; tRNA cloverleaf → L shape |
| Alkali | Hydrolyses RNA (2’-OH); only denatures DNA |
| Duplex stability | Stacking > H-bonds; Tm ↑ with GC and salt; ↓ with formamide, urea |
| Tm | 69.3 + 0.41(%GC) °C (Marmur–Doty); oligos 2(A+T) + 4(G+C) |
| Hyperchromicity | A₂₆₀ rises on melting |
| A₂₆₀ = 1 | 50 µg/mL dsDNA; 40 RNA; about 33 ssDNA; A₂₆₀/A₂₈₀ about 1.8 for pure DNA |
Vitamins
| Vitamin | Coenzyme / action |
|---|---|
| B₁ | TPP: PDH, α-KGDH, transketolase |
| B₂ | FMN, FAD |
| B₃ | NAD⁺, NADP⁺ (also from Trp) |
| B₅ | CoA, ACP |
| B₆ | PLP: transamination, decarboxylation, glycogen phosphorylase |
| B₇ | Biotin: carboxylases (pyruvate, acetyl-CoA, propionyl-CoA) |
| B₉ | THF: one-carbon units |
| B₁₂ | Methylcobalamin (methionine synthase); deoxyadenosylcobalamin (methylmalonyl-CoA mutase) |
| C | Prolyl/lysyl hydroxylases (collagen) |
| A | 11-cis-retinal (rhodopsin); retinoic acid (nuclear receptor) |
| D | Liver 25-OH, kidney 1α-OH → calcitriol |
| K | γ-Carboxylation of Glu; warfarin blocks epoxide reductase |
| E | Membrane antioxidant |
Proteins
| Fact | Detail |
|---|---|
| Peptide bond | Planar, trans, partial double bond (C–N about 1.32 Å) |
| Torsions | φ (N–Cα), ψ (Cα–C), ω about 180° |
| α-helix | φ −57°, ψ −47°; 3.6 residues/turn, 1.5 Å/residue, 5.4 Å pitch; C=O(i)…H–N(i+4); right-handed |
| β-sheet | Antiparallel −139°, +135°; parallel −119°, +113° |
| Left-handed region (φ > 0) | Mostly Gly |
| Pro | φ fixed near −60°; no N–H; helix breaker; turns |
| β-turn | 4 residues; i → i+3; Gly, Pro |
| Collagen | Gly–X–Y (Pro, Hyp); left-handed chains, right-handed triple helix |
| Motifs | HTH (repressors), C₂H₂ zinc finger, leucine zipper (heptad), EF-hand (Ca²⁺), βαβ (right-handed) |
| Folds | Rossmann (NAD⁺), TIM barrel (βα)₈, Ig β-sandwich, four-helix bundle |
| Anfinsen | RNase A, 8 M urea + β-ME; 105 disulfide combinations; sequence specifies fold |
| Folding | Funnel, molten globule; Hsp70, GroEL/GroES, PDI, PPIase |
| Stability | Marginal; hydrophobic effect dominant; disulfides lower entropy of U |
| Two-state | K = f_U/(1 − f_U); at Tm ΔG = 0, ΔS = ΔH/Tm; ΔCp > 0 → cold denaturation |
| CD | α: minima 222 and 208 nm; β: 218 nm; coil: about 200 nm |
| Trp fluorescence | Red-shifts on unfolding |
Enzymes
| Fact | Detail |
|---|---|
| EC classes | 1 Oxidoreductase, 2 Transferase, 3 Hydrolase, 4 Lyase, 5 Isomerase, 6 Ligase, 7 Translocase |
| Catalysis | TS binding; acid–base, covalent, metal ion, proximity, electrostatic |
| Chymotrypsin | Ser195, His57, Asp102; oxyanion hole; acyl-enzyme; burst kinetics; DIFP labels Ser |
| Specificity pockets | Chymotrypsin aromatic; trypsin Lys/Arg; elastase small |
| Michaelis–Menten | v₀ = Vmax[S]/(Km + [S]); Km = (k₋₁ + k₂)/k₁ |
| Saturation | [S] = Km → 50%; 3Km → 75%; 9Km → 90% |
| kcat, kcat/Km | Turnover; specificity constant; diffusion limit 10⁸–10⁹ M⁻¹ s⁻¹ |
| Lineweaver–Burk | y = 1/Vmax; x = −1/Km; slope Km/Vmax |
| Competitive | Km × α, Vmax same; lines cross on y-axis |
| Uncompetitive | Km and Vmax ÷ α’; parallel lines |
| Pure non-competitive | Vmax ÷ α, Km same; cross on x-axis |
| Kᵢ | α = 1 + [I]/Kᵢ |
| Ping-pong | Parallel lines; aminotransferases |
| Suicide inhibitors | 5-FU (thymidylate synthase), DFMO (ODC) |
| Allostery | Sigmoid; K₀.₅; homotropic/heterotropic; MWC (concerted) vs KNF (sequential) |
| Hill | n_H > 1 positive; 10→90% needs 81^(1/n_H)-fold [S]; Hb about 3 |
| ATCase | CTP inhibits, ATP activates |
| Zymogens | Trypsinogen ← enteropeptidase; trypsin activates the rest |
| Isozymes | LDH (H₄ … M₄); hexokinase (Km about 0.1 mM) vs glucokinase (about 10 mM); CK-MM/MB/BB |
Bioenergetics
| Fact | Detail |
|---|---|
| ATP hydrolysis | ΔG°’ −30.5 kJ/mol; cellular ΔGp about −50 to −65 |
| Group transfer ladder | PEP −61.9 > 1,3-BPG −49.3 > PCr −43.0 > ATP −30.5 > G1P −20.9 > G6P −13.8 > glycerol-3-P −9.2 |
| Coupling | Glucose + ATP → G6P + ADP: +13.8 − 30.5 = −16.7 kJ/mol |
| E°' | NAD⁺/NADH −0.320; fumarate/succinate +0.031; Q +0.045; cyt c +0.254; O₂/H₂O +0.816 V |
| NADH → O₂ | ΔE°’ 1.136 V; ΔG°’ −219 kJ/mol |
| H⁺ pumped | I: 4, III: 4, IV: 2; II: 0 → 10 per NADH, 6 per succinate |
| H⁺ per ATP | 4 (3 synthase + 1 Pᵢ transport) |
| P/O | 2.5 (NADH), 1.5 (FADH₂) |
| Inhibitors | Rotenone, amytal (I); malonate (II); antimycin A (III); CN⁻, CO, azide (IV); oligomycin (F₀); atractyloside, bongkrekic acid (ANT) |
| Uncouplers | DNP, FCCP, UCP1 (thermogenin): O₂ use ↑, ATP ↓ |
| ATP synthase | Binding change (O, L, T); rotation of γ |
| Δp | ΔG per H⁺ = 2.303RTΔpH + FΔψ |
Metabolism
| Fact | Detail |
|---|---|
| Glycolysis net | 2 ATP, 2 NADH, 2 pyruvate |
| Irreversible steps | Hexokinase, PFK-1, pyruvate kinase |
| PFK-1 | Inhibited by ATP, citrate; activated by AMP, F2,6BP |
| Inhibitors | Iodoacetate (GAPDH), arsenate (uncouples step 6–7), fluoride (enolase) |
| PDH | TPP, lipoamide, CoA, FAD, NAD⁺; phosphorylation inactivates |
| Gluconeogenesis | Pyruvate carboxylase (biotin) + PEPCK (GTP); FBPase-1; G6Pase (not in muscle); 4 ATP + 2 GTP + 2 NADH |
| PPP | G6PD rate-limiting; 2 NADPH + CO₂ per G6P; transketolase (TPP), transaldolase |
| Glycogen | Phosphorylase (PLP) → G1P; synthase uses UDP-glucose; phosphorylase a active, synthase a active |
| TCA per acetyl-CoA | 3 NADH, 1 FADH₂, 1 GTP, 2 CO₂ |
| TCA inhibitors | Malonate (SDH), fluorocitrate (aconitase), arsenite (lipoamide) |
| Glyoxylate cycle | Isocitrate lyase + malate synthase; plants, bacteria |
| Glucose yield | 30 or 32 ATP |
| Fatty acid activation | 2 ATP equivalents; carnitine shuttle; CPT-I inhibited by malonyl-CoA |
| Palmitate | 8 acetyl-CoA, 7 FADH₂, 7 NADH → 106 ATP |
| Odd-chain | Propionyl-CoA → (biotin) → methylmalonyl-CoA → (B₁₂) → succinyl-CoA |
| Ketone bodies | Liver makes (HMG-CoA synthase), cannot use (no thiophorase) |
| FA synthesis | ACC (biotin; citrate +, palmitoyl-CoA −, AMPK −); 7 ATP + 14 NADPH per palmitate |
| Cholesterol | HMG-CoA reductase (statins); C5 → C10 → C15 → squalene C30 → lanosterol → C27 |
| Urea cycle | CPS I (N-acetylglutamate), OTC (mito); ASS, ASL, arginase (cytosol); N from NH₄⁺ and Asp; 4 ~P |
| Ketogenic only | Leu, Lys |
| Essential amino acids | His, Ile, Leu, Lys, Met, Phe, Thr, Trp, Val |
| Inborn errors | PKU, alkaptonuria, MSUD, albinism, homocystinuria |
| Purine atoms | N1 Asp; C2, C8 formyl-THF; N3, N9 Gln; C4, C5, N7 Gly; C6 CO₂; first purine IMP |
| Purine control | Gln-PRPP amidotransferase; AMP needs GTP, GMP needs ATP |
| Purine salvage / breakdown | HGPRT (Lesch–Nyhan); xanthine oxidase (allopurinol, gout); ADA (SCID) |
| Pyrimidines | CPS II (Gln, cytosol) → ATCase → … orotate → OMP → UMP → CTP |
| dNTPs | Ribonucleotide reductase on NDPs; dATP inhibits; thioredoxin |
| dTMP | Thymidylate synthase (methylene-THF → DHF); DHFR (methotrexate); 5-FU |
| Glucose carbons → pyruvate | C1, C6 → methyl; C2, C5 → carbonyl; C3, C4 → carboxyl |
Ten-Second Formula Card
$$\mathrm{pH} = \mathrm{p}K_a + \log\frac{[\mathrm{A^-}]}{[\mathrm{HA}]} \qquad \Delta G = \Delta G^{\circ\prime} + RT\ln Q \qquad \Delta G^{\circ\prime} = -RT\ln K'_{eq} = -nF\Delta E^{\circ\prime}$$$$v_0 = \frac{V_{max}[S]}{K_m + [S]} \qquad \frac{1}{v_0} = \frac{K_m}{V_{max}}\frac{1}{[S]} + \frac{1}{V_{max}} \qquad \alpha = 1 + \frac{[I]}{K_I}$$$$Lk = Tw + Wr \qquad T_m = 69.3 + 0.41(\%\mathrm{GC}) \qquad \pi = iMRT \qquad t_{1/2} = \frac{0.693}{k}$$What’s Next
- Go back to the chapter overview and redo the Level 3 questions on each page without looking at the solutions.
- Life Sciences & Biotechnology — the full 14-unit syllabus.
- Chemical Sciences — physical chemistry for deeper kinetics and thermodynamics.